Reports Q3 revenue $35.7M vs $39.5M last year. “Ultralife’s (ULBI) third quarter results were weighed down by the timing of expected larger purchase orders for our Communications Systems segment and by the muted growth for our Battery & Energy Products segment due to some supply chain timing and customers’ requests delaying orders into the fourth quarter and first half of 2025. While we are not satisfied with these results, they do illustrate how fluctuations in order timing and periodic disruptions in our supply chain can impact our business on a short-term basis,” said Mike Manna, President and Chief Executive Officer. “I am thrilled we completed our acquisition of Electrochem on October 31st. We look forward to implementing our integration playbook to advance our strategy of more fully realizing the operating leverage of our business model through scale and manufacturing cost efficiencies, while creating highly attractive opportunities to further drive revenue growth through heightened cross-selling and extending our reach into underserved adjacent markets.”
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ULBI:
- Ultralife Completes Electrochem Acquisition and Secures Financing
- Ultralife completes acquisition of Electrochem Solutions for $50M in cash
- Integer completes sale of Electrochem business to Ultralife
- ULBI Upcoming Earnings Report: What to Expect?
- Ultralife Expands Portfolio with Electrochem Acquisition